Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Link opens in a new tab
Search content at Icahn School of Medicine at Mount Sinai
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Calcipotriene and corticosteroid combination therapy for vitiligo
Lisa B. Travis
,
Nanette B. Silverberg
Research output
:
Contribution to journal
›
Article
›
peer-review
62
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Calcipotriene and corticosteroid combination therapy for vitiligo'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Corticosteroids
100%
Calcipotriol
100%
Combination Therapy
100%
Vitiligo
100%
Repigmentation
60%
Topical Corticosteroids
60%
Phototherapy
40%
Mechanism of Action
20%
Psoriasis
20%
Monotherapy
20%
Body Surface Area
20%
Lack of Response
20%
Adverse Reactions
20%
Two-agent
20%
Eyelid Skin
20%
Psoralen
20%
Facial Skin
20%
Medicine and Dentistry
Combination Therapy
100%
Vitiligo
100%
Calcipotriol
100%
Corticosteroid
100%
Topical Corticosteroid
60%
Monotherapy
20%
Phototherapy
20%
Psoriasis
20%
Body Surface
20%
PUVA
20%
Facial Skin
20%
Adverse Drug Reaction
20%
Photochemotherapy
20%
Side Effect
20%
Pharmacology, Toxicology and Pharmaceutical Science
Combination Therapy
100%
Calcipotriol
100%
Vitiligo
100%
Corticosteroid
100%
Topical Corticosteroid
60%
Adverse Drug Reaction
20%
Monotherapy
20%
Psoriasis
20%
Photodynamic Therapy
20%
Psoralen
20%
Side Effect
20%
Neuroscience
Corticosteroid
100%
Calcipotriol
100%
Psoralen
20%
Side Effect
20%